Table 2.
Clinical parameters
| Number of individuals | CD | UC | Controls |
|---|---|---|---|
| 13 | 20 | 12 | |
| Age (median years (range)) | 31 (19-59) | 46 (18-68) | 54 (18-77) |
| Average age at diagnosis (years) | 27 | 33 | NA |
| Average years with disease (disease duration) | 8 | 9.3 | NA |
| Female/male | 6/7 | 13/7 | 8/4 |
| Smoking | |||
| Smoker (S) | 8 | 1 | 4 |
| Previous (P) | 4 | 8 | 1 |
| Never (N) | 1 | 11 | 5 |
| Not disclosed (ND) | - | - | 2 |
| Ethnicity | |||
| Danish (DK) | 9 | 19 | 12 |
| European (EU) | 1 | - | - |
| Middle Eastern (ME) | 3 | 1 | - |
| Number of individuals with family history of other autoimmune diseases | 1 (7%) | 6 (30%) | 5 (41%) |
| Number of patients on medication | NA | ||
| 5-ASA | 2 | 13 | |
| Solumedrol | 2 | 1 | |
| Azathioprin | 2 | 2 | |
| Budesonide | 1 | 1 | |
| Prednisolon | 1 | 2 | |
| Disease index | HB index = 3-36 | SCCAI index = 2-12 |
Each column summarizes characteristics for all patients contributing samples to the corresponding sample groups. 5-ASA, 5-aminosalicylic acid; HB index, Harvey Bradshaw index; NA, not applicable; SCCAI index; Simple Clinical Colitis Activity index.